IL17A and COVID-19: Higher percentages of CD4+ T cells producing IFNγ, TNFα, IL-2, and IL-17A and CD8+ T cells producing IL-2 and IL-17A have been detected by flow cytometry in PBMCs from COVID-19 patients vs. healthy controls after in vitro stimulation (De Biasi et al., 2020).